Form 4: BridgeBio Pharma Director Francis McCormick Reports Stock Transfers

Director Francis McCormick reported gifting shares of BridgeBio Pharma stock, both directly and indirectly through a trust.

Summary

• On May 7, 2025, Director Francis McCormick gifted 33,000 shares of BridgeBio Pharma (BBIO) common stock.
• On May 8, 2025, McCormick gifted an additional 3,000 shares of BBIO common stock.
• Following these transactions, McCormick directly owns 76,686 shares.
• McCormick also indirectly owns 979,979 shares through the Francis P. McCormick Rev Trust U/A DTD 1/27/2017.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't convey any inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider and doesn't necessarily reflect a broader trend in the pharmaceutical industry.

Stakeholder Impact

• The gifting of shares by a director could be perceived differently by stakeholders; some may see it as a charitable act, while others might interpret it as a lack of confidence, although gifting is a common estate planning strategy.

Key Dates

Keywords

BridgeBio Pharma, BBIO, Director, Francis McCormick, Stock, Gift, Beneficial Ownership, Form 4, SEC